Биологические и клинико-морфологические аспекты учения о метастазировании злокачественных опухолей

Обложка

Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

С клинической и особенно прогностической точки зрения метастазирование представляет собой важнейший этап в патогенезе злокачественных опухолей. Именно поэтому его усиленно изучают. За последние 5-6 лет объем научной информации по этой проблеме резко возрос. Опубликовано огромное число данных, полученных в онкологической практике, онкоморфологии, экспериментальной онкологии, онкоцитогенетике и биохимии новообразований. В статье, имеющей обзорный характер, суммированы и обсуждены новейшие сведения по проблеме метастазирования, представленные в трудах по указанным областям онкологии, а также результаты собственных работ.

Об авторах

Н. М. Аничков

Государственная медицинская академия им. И. И. Мечникова

Автор, ответственный за переписку.
Email: shabanov@mail.rcom.ru

Член-корреспондент РАМН

Россия, Санкт-Петербург, 195067, Пискаревский пр., 47

Список литературы

  1. Аничков Н.М. К учению о метастазировании злокачественных опухолей // Сб. науч. тр. «Патоморфология в Санкт-Петербурге» / Ред. Н. М. Аничков. Российское отд. Междунар. акад. патологии. СПб., 1993. С. 16-25.
  2. Аничков Н.М., Борисов А. В., Габуния У. А. Лимфатические пути и метастазирование рака. Тбилиси: Мецниереба, 1989. 128 с.
  3. Aparicio Т., Kermorgant S., Dessirier V. et al. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats // Carcinogenesis. 1999. Vol. 20. P. 1445-1451.
  4. Baker A.H., George S.J., Zaltsman A.B. et al. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 // Br. J. Cancer. 1999. Vol. 79. P. 1347-1355.
  5. Barinaga M. Designing therapies that target tumor blood vessels [news; comment] // Science. 1997. Vol. 275. P. 482-484.
  6. Bauer K.S., Figg W.D., Hamilton J.M. et al. A pharmacokinetically guided phase II study of carboxyamidotriazole in androgen-independent prostate cancer // Clin. Cancer Res. 1999. Vol. 5. P. 2324-2329.
  7. Berx G., Cleton Jansen A. M., Strumane K. et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain // Oncogene. 1996. Vol. 13. P. 1919-1925.
  8. Bigg H.F, Shi Y.E., Liu Y.E. et al. Specific, high affinity binding of tissue inhibitor of metallopro- teinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH- terminal domain in a similar manner to TIMP-2 // J. Biol. Chem. 1997. Vol. 272. P. 15496-15500.
  9. Brown J. D., Moon R. T. Wnt signaling: why is everything so negative? // Curr. Opin. Cell Biol. 1998. Vol. 10. P. 182-187.
  10. Butler G.S., Apte S.S., Willenbrock F., Murphy G. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-termi-nal domains of gelatinases A and B. Regulation by polyanions // J. Biol. Chem. 1999. Vol. 274. P. 19846-10851.
  11. Chambers A. F., Matrisian L. M. Changing views of the role of matrix metalloproteinases in metastases // J. Natl. Cancer Inst. 1997. Vol. 89. P. 1260-1270.
  12. Chen H., Paradies N.E., Fedor C.M., Bracken- bury R. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms // J.Cell Sci. 1997. Vol. 110. P. 345-356.
  13. Dezube B.J., Von Roenn J. H., Holden IV. J. et al. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study // J. Clin. Oncol. 1998. Vol. 16. P. 1444-1449.
  14. Eckhardt S. G., Pluda J. M. Development of angiogenesis inhibitors for cancer therapy // Invest. New Drugs. 1997. Vol. 15. P. 1-3.
  15. Engers R., Gerharz C.D., Donner A. et al. In vitro invasiveness of human epithelioid-sarcoma cell lines: association with cell motility and inverse correlation with the expression of tissue inhibitor of metalloproteinases // Int. J. Cancer. 1999. Vol. 80. P. 406-412.
  16. Engers R., Gabbert H. E. Mechanisms of tumor metastasis: cell biological aspects and clinical implications // J. Cancer Res. Clin. Oncol. 2000. Vol. 126. P. 682-692.
  17. Evans T. R., Kaye S. B. Retinoids: present role and future potential // Br. J. Cancer. 1999. Vol. 80. P. 1-8.
  18. Folkman J. Angiogenesis and angiogenesis inhibition: an overview // EXS. 1997. Vol. 79. P. 1-8.
  19. Giancotti F. G., Ruoslahti E. Integrin signaling // Science. 1999. Vol. 285. P. 1028-1032.
  20. Gomez D. E., Alonso D. E, Yoshiji H, Thor-geirs- son U. P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions // Eur. J. Cell Biol. 1997. Vol. 74. P. 111-122.
  21. Harris A. L. Anti-angiogenesis therapy and strategies for intergrating it with adjuvant therapy // Recent Results Cancer Res. 1998. Vol. 152. P. 341-352.
  22. Hart I.R. Perspective: tumor spread - the problems of latency // J. Pathol. 1999. Vol. 187. P. 91-94.
  23. Hejna M., Raderer M., Zielinski С. C. Inhibition of metastases by anticoagulants // J. Natl. Cancer Inst. 1999. Vol. 91. P. 22-36.
  24. Hӧfler H. Diffuse-type gastric cancer: from H&E-diagnosis and molecular pathology to specific therapy // Verh. Dtsch. Ges. Path. 1999. Bd. 83. S. 148-254.
  25. Hordijk P.L., ten Klooster J.P., van der Kammen R. A. et al. Inhibition of invasion of epithelial cells by Tiaml-Rac signaling // Science. 1997. Vol. 278. P. 1464-1466.
  26. Jiang W. G. Cell adhesion molecules in the formation of liver metastasis // J. Hepatobiliary Pancreat. Surg. 1998 (a). Vol. 5. P. 375-382.
  27. Jiang W. G. Regulation of cell adhesion: a central mechanism in the anticancer action of essential fatty acids (review) // Int. J. Mol. Med. 1998 (b). Vol. 1. P. 621-625.
  28. Jiang W.G., Bryce R.P, Horrobin D.F, Mansei R. E. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids // Biochem. Biophys. Res. Commun. 1998. Vol. 244. P. 414-420.
  29. Keely P.J., Westwick J. K, Whitehead I.P. et al. Cdc42 and Rac 1 induce integrin-mediated cell motility and invasiveness through PI(3)K // Nature. 1997. Vol. 3 90. P. 63 2-63 6.
  30. Kim L. T., Yamada К M. The regulation of expression of integrin receptors // Proc. Soc. Exp. Biol. 1997. Vol. 214. P. 123-131.
  31. Kuroda S., Fukata M., Nakagawa M., Fujii K. et al. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac 1, in regulation of E-cad- herin-mediated cell-cell adhesion // Science. 1998. Vol. 281. P. 832-835.
  32. Kuroda S., Fukata M., Nakagawa M., Kaibuchi K. Cdc42, Rac 1 and their effector IQGAP1 as molecular switches for cadherin-mediated cellcell adhesion // Biochem. Biophys. Res. Commun. 1999. Vol. 262. P. 1-6.
  33. Leger O.J., Yednock T.A., Tanner L. et al. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis // Hum. Antibodies. 1997. Vol. 8. P. 3-16.
  34. Lin К. C., Castro A. C. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents // Curr. Opin. Chem. Biol. 1998. Vol. 2. P. 453-457.
  35. Lode H.N, Moehler T., Xiang R. et al. Synergy between an antiangiogenic integrin alpha-v antagonist and an antibody-cytikine fusion protein eradicates spontaneous tumor metastases // Proc. Natl. Acad. Sci. USA. 1999. Vol. 96. P. 1591-1596.
  36. Macaulay V.M., O'Byrne K. J., Saunders M. P. et al. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions // Clin. Cancer Res. 1999. Vol. 5. P. 513-520.
  37. Mainiero F., Murgia C., Wary К. K. et al. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation // EMBO J. 1997. Vol. 16. P. 2365-2375.
  38. Marches R., Scheuermann R. H., Uhr J. W. Cancer dormancy: role of cycline-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM // Cancer Res. 1998. Vol. 58. P. 691-697.
  39. Mareel M., Boterberg T., Noe V. et al. E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion // J. Cell Physiol. 1997. Vol. 173. P. 271-274.
  40. Meiners S., Brinkmann V., Naundorf H., Birchmeier W. Role of morphogenetic factors in metastasis of mammary carcinoma cells // Oncogene. 1998. Vol. 16. P. 9-20.
  41. Meyer T., Hart I. R. Mechanisms of tumour metastasis // Eur. J. Cancer. 1998. Vol. 34. P. 214-221.
  42. Mohanam S., Chintala S.K., Go Y. et al. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor // Oncogene. 1997. Vol. 14. P. 1351-1359.
  43. Nakanishi Y., Ochiai A., Akimoto S. et al. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions // Oncology. 1997. Vol. 54. P. 158-165.
  44. Nobes C. D., Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement // J. Cell Biol. 1999. Vol. 144. P. 1235-1244.
  45. Palacios J., Gamallo C. Mutations in the beta- catenin gene (CTNNB1) in endometrioid ovarian carcinomas // Cancer Res. 1998. Vol. 58. P. 1344-1347.
  46. Palecek S.P, Loftus J. C., Ginsberg M. H. et al. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness // Nature. 1997. Vol. 385. P. 537-540.
  47. Perl A. K., Wilgenbus P., Dahl U., Semb E., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma // Nature. 1998. Vol. 392. P. 190-193.
  48. Rabbani S. A., Xing R. H. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies // Int. J. Oncol. 1998. Vol. 12. P. 911-920.
  49. Reuning U., Magdolen V., Wilhelm O. et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review) // Int. J. Oncol. 1998. Vol. 13. P. 893-906.
  50. Ruoslahti E. Integrins as signaling molecules and targets for tumor therapy // Kidney Int. 1997. Vol. 51. P. 1413-1417.
  51. Sabichi A. L., Lerner S., Grossman H. B., Lippman S. M. Retinoids in the chemoprevention of bladder cancer // Curr. Opin. Oncol. 1998. Vol. 10. P. 479-484.
  52. SanderE. E., van Delft S., ten Kloos ter J. P. et al. Matrix-dependent Tiaml/Rac signaling in epithelial cells promoters either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase // J. Cell Biol. 1998. Vol. 143. P. 1385-1398.
  53. Shaw L. M., Rabinovitz I., Wang H. H. et al. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion // Cell. 1997. Vol. 91. P. 949-960.
  54. Sheetz M. P., Felsenfeld D., Galbraith C. G., Choquet D. Cell migration as a five-step cycle // Biochem. Soc. Symp. 1999. Vol. 65. P. 223-243.
  55. Torzewski M., Sarbia M., Verreet P. et al. Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinomas of the esophagus // Clin Cancer Res. 1997. Vol. 3. P. 2263-2268.
  56. Vassilev T. L., Kazatchkine M. D., Van Huyen J. P. et al. Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg) // Blood. 1999. Vol. 93. P. 3624-3 631.
  57. Vitetta E. S., Tucker T. F., Racila E. et al. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established // Blood. 1997. Vol. 89. P. 4425-4436.
  58. Wang M., Liu Y. E., Greene J. et al. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4 // Oncogene. 1997. Vol. 14. P. 2767-2774.
  59. Wylie S., MacDonald I. C., Varghese H. J. et al. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells // Clin. Exp. Metastasis. 1999. Vol. 17. P. 111-117.
  60. Yap A. S., Brieher W. M., Gumbiner В. M. Molecular and functional analysis of cadherinbased adherens junctions // Annu. Rev. Cell Dev. Biol. 1997. Vol. 13. P. 119-146.
  61. Yoshioka T., Masuko T., Kotanagi H. et al. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development // Jpn. J. Cancer Res. 1998. Vol. 89. P. 177-185.
  62. Yoshioka K, Nakamori S., Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells // Cancer Res. 1999. Vol. 59. P 2004-2010.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Эко-Вектор, 2003


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.